/Investor DB

xfactor ventures — 2021 Investments

10 investments dated 2021 · listed companies and verified rows first · show all

Tinyandtiny.comin𝕏OTC: TNYZFJun 2021 · $11M

Tiny builds an ERP platform that uses AI agents to handle routine manufacturing tasks for factories, targeting the large share of production facilities still dependent on spreadsheets and unstructured data systems.

ConsumerEnterprise SoftwareSaaSSingapore, SG

Edward Zhang(Founder)inChris Sparling(Executive Officer, Director)Jordan Taub(Executive Officer)inMike McKenna(Executive Officer)Andrew Wilkinson(Executive Officer, Director)Evan Brown(Executive Officer)

Co-investorsAtento CapitalBlueRun VenturesD&FG ElementsY CombinatorGaingelsHuman Ventures+3 more

AltrixBioaltrixbio.comSeed · Jan 2021

AltrixBio develops AJN003, a non-systemic, once-daily oral therapy for type 2 diabetes and related metabolic conditions that transiently coats the stomach and upper intestine to shift nutrient sensing and trigger a metabolic reset similar to bariatric surgery.

BiotechDigital HealthWilmington, US

Ali Tavakkoli(Co-founder)Nancy Briefs(Executive Chair of the Board & Founder)inJeff Karp(Co-founder)

BoardJohn Brooks(Director)

Co-investorsService Provider CapitalTaihill VentureWalnut Venture Associates

Front of the Packfotp.comSeries A · Jul 2021 · $10M

Front of the Pack sells a daily powdered dog supplement called The One, formulated with clinically studied ingredients to support canine joint, gut, and mental health.

ConsumerDirect to ConsumerWellness & Fitness

Jamie Peyton(Chief Science Officer (DVM, DACVECC, CVA, CVC, CCRT))

Co-investorsHeartcore CapitalMatrix

Loveverylovevery.comSeries C · Jun 2021 · $100M

Lovevery designs play products for babies and young children based on child development research and neuroscience.

ConsumerEdTechWellness & FitnessBoise, US

Rod(Co-founder)Jessica Rolph(Founder)inRoderick Morris(Founder)in

Co-investorsCollaborative FundEastward Capital PartnersFounder CollectiveGV (Google Ventures)MaveronReach Capital+3 more

NaluBio, Inc.nalubio.cominSeed · Jan 2021 · $2M

Nalu Bio develops an AI-powered drug discovery platform targeting the endocannabinoid system to create therapeutics for inflammatory, immune, and metabolic diseases.

AI & Machine LearningBiotechHealthtechMedical DevicesSan Francisco, US

Caitlyn Krebs(Co-founder + CEO)inPhyllis Whiteley(Co-founder + Board Member)inRandall Ussery(Co-founder + Board Member)Howard Goodwin(Director)

Co-investorsBonaventure Equity, LLCFlybridge Capital PartnersPortfoliaGolden Seeds

Stardaystardayfoods.comSeed · Aug 2021 · $4M

Starday is an AI-enabled innovation partner for food and beverage companies, helping teams prioritize, develop, and launch new products through expert guidance, defined processes, and internal technology.

AI & Machine LearningConsumerFoodTech

Lily Burtis(Founder)in

Co-investorsAZ Venture Capital Inc.City LightEqual VenturesGreat Oaks Venture CapitalHannah Grey VenturesPure Ventures+3 more

Tiny Organicstinyorganics.comin𝕏Jun 2021

New York-based DTC subscription brand of organic, plant-based finger-food meals for toddlers.

New York, US

Sofia Laurell(Director)inBetsy Fore(Executive Officer, Director)in

BoardVictor Friedberg(Director)Andrew Heintzman(Director)inGenevieve Gilbreath(Director)in

Co-investorsElizabeth Street VenturesInvestEcoVegInvestGaingelsHuman VenturesRocana Ventures+2 more

Veracity Healthveracityhealth.coSeed · Sep 2021 · $5M

Veracity Health develops a metabolic health product that targets cellular energy metabolism to support sustainable weight loss and overall health benefits.

ConsumerDirect to ConsumerHealthtechWellness & Fitness

Allie Egan(Founder)inGabrielle Francis(Chief Medical Officer)

Co-investors37 AngelsCartan CapitalCoalition OperatorsGreat Oaks Venture CapitalMaveronMelitas Ventures Llc+7 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Liberare (Formerly Intimately)Park Place Payments

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.